BR0213186A - 4-(2-furoil)aminopiperidinas, intermediários na sìntese dos mesmos, processo para produzir os mesmos e uso medicinal dos mesmos - Google Patents

4-(2-furoil)aminopiperidinas, intermediários na sìntese dos mesmos, processo para produzir os mesmos e uso medicinal dos mesmos

Info

Publication number
BR0213186A
BR0213186A BR0213186-2A BR0213186A BR0213186A BR 0213186 A BR0213186 A BR 0213186A BR 0213186 A BR0213186 A BR 0213186A BR 0213186 A BR0213186 A BR 0213186A
Authority
BR
Brazil
Prior art keywords
group
chem
furoyl
formula
aminopiperidines
Prior art date
Application number
BR0213186-2A
Other languages
English (en)
Inventor
Ryuuta Fukutomi
Hitoshi Inoue
Koji Kawamura
Takuya Kishimoto
Masashi Suzuki
Rie Shibayama
Kazuko Kojima
Kouichirou Hagihara
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of BR0213186A publication Critical patent/BR0213186A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"4-(2-FUROIL)AMINOPIPERIDINAS, INTERMEDIáRIOS NA SìNTESE DOS MESMOS, PROCESSO PARA PRODUZIR OS MESMOS E USO MEDICINAL DOS MESMOS". A invenção refere-se a novas 4-(2-furoil)aminopiperidinas representadas pela fórmula geral (I), seus intermediários sintéticos, processos para sua preparação e medicamentos contendo-as. Na fórmula acima, X é CH ou N e Y é um grupo seguinte fórmula geral (II), fórmula (II-a) ou fórmula (III): nas quais: a, b e c são cada qual um número inteiro de 0 a 6; Z é CH~ 2~ ou NH; W é O ou S; T é O ou N-R^ 15^ onde R^ 15^ é H, um grupo C~ 1~-C~ 6~ alquila, um grupo benzila ou um grupo fenetila; e R^ 1^ é H, um grupo C1-C6 alcoxicarbonila, um grupo benzilóxi-carbonila ou similares. Os derivados de 4-(2-furoil)aminopiperidina de acordo com esta invenção possui atividade antagonística <109> opióide e são úteis para o tratamento ou prevenção de efeitos colaterais que são causados por agonista de receptores <109> e que são selecionados de constipação, náusea/êmese ou sarna ou para o tratamento ou prevenção de constipação idiopática, íleo pós-operatório, íleo paralítico, síndrome do intestino irritável ou prurido crónico.
BR0213186-2A 2001-10-09 2002-10-08 4-(2-furoil)aminopiperidinas, intermediários na sìntese dos mesmos, processo para produzir os mesmos e uso medicinal dos mesmos BR0213186A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001311828 2001-10-09
PCT/JP2002/010449 WO2003035645A1 (fr) 2001-10-09 2002-10-08 Nouvelles 4-(2-furoyl)aminopiperidines, intermediaires utilises dans la synthese de ces dernieres, leur procede de production et leur utilisation medicale

Publications (1)

Publication Number Publication Date
BR0213186A true BR0213186A (pt) 2004-08-10

Family

ID=19130581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213186-2A BR0213186A (pt) 2001-10-09 2002-10-08 4-(2-furoil)aminopiperidinas, intermediários na sìntese dos mesmos, processo para produzir os mesmos e uso medicinal dos mesmos

Country Status (14)

Country Link
US (2) US7375115B2 (pt)
EP (1) EP1443046B1 (pt)
JP (1) JP4009251B2 (pt)
KR (1) KR100938369B1 (pt)
CN (1) CN1326853C (pt)
AT (1) ATE417845T1 (pt)
BR (1) BR0213186A (pt)
CA (1) CA2468529C (pt)
DE (1) DE60230437D1 (pt)
DK (1) DK1443046T3 (pt)
ES (1) ES2319879T3 (pt)
MX (1) MXPA04003330A (pt)
PT (1) PT1443046E (pt)
WO (1) WO2003035645A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099194A1 (ja) * 2003-05-08 2004-11-18 Kyorin Pharmaceutical Co. Ltd. 掻痒治療薬として有用な４－（２－フロイル）アミノピペリジン類
JP2004352714A (ja) * 2003-05-08 2004-12-16 Kyorin Pharmaceut Co Ltd 新規な４−（２−フロイル）アミノピペリジン誘導体
EP1622613A4 (en) * 2003-05-14 2008-04-02 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
AR057959A1 (es) * 2005-12-01 2007-12-26 Elan Pharm Inc 5-pirazolpiperidinas-(sustituidas)
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
JP4898287B2 (ja) * 2006-05-17 2012-03-14 杏林製薬株式会社 ［１−［２−［４−［ｎ−（５−メチルピリジン−２−イル）−２−フランカルボキサミド］ピペリジン−１−イル］エチル］シクロヘキシル］アセトヒドロキサム酸の製造方法
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011416A (es) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida.
RS52518B (sr) 2007-04-23 2013-04-30 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajući dopamin 2 receptorski antagonisti
US20100137368A1 (en) * 2007-04-23 2010-06-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
ES2622161T3 (es) 2008-07-31 2017-07-05 Janssen Pharmaceutica, N.V. Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20120142932A1 (en) * 2009-09-08 2012-06-07 Koji Kawamura Method for manufacturing 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivative
JP2013537240A (ja) * 2010-09-20 2013-09-30 カリウス セラピューティクス エスエー 糖尿病および脂質異常症の処置のための方法および組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112984A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd １，４−ベンゾジアゼピン誘導体
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4912109A (en) * 1987-02-02 1990-03-27 Boc, Inc. N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
JPH09501404A (ja) 1993-05-26 1997-02-10 スミスクライン・ビーチャム・ラボラトワール・ファルマソーティク 新規化合物

Also Published As

Publication number Publication date
CA2468529C (en) 2011-03-01
ATE417845T1 (de) 2009-01-15
CN1582286A (zh) 2005-02-16
EP1443046A4 (en) 2005-11-16
DE60230437D1 (de) 2009-01-29
ES2319879T3 (es) 2009-05-14
KR20040039495A (ko) 2004-05-10
CA2468529A1 (en) 2003-05-01
EP1443046B1 (en) 2008-12-17
DK1443046T3 (da) 2009-04-14
JPWO2003035645A1 (ja) 2005-02-10
MXPA04003330A (es) 2004-07-08
WO2003035645A1 (fr) 2003-05-01
JP4009251B2 (ja) 2007-11-14
US20080194826A1 (en) 2008-08-14
PT1443046E (pt) 2009-02-26
US20050085508A1 (en) 2005-04-21
CN1326853C (zh) 2007-07-18
KR100938369B1 (ko) 2010-01-22
US7375115B2 (en) 2008-05-20
EP1443046A1 (en) 2004-08-04

Similar Documents

Publication Publication Date Title
BR0213186A (pt) 4-(2-furoil)aminopiperidinas, intermediários na sìntese dos mesmos, processo para produzir os mesmos e uso medicinal dos mesmos
BR9408351A (pt) Composto composição farmacêutica processos para antagonizar o efeito de substância p e de neuroquinina a no seu sitio receptor processos para tratamento ou prevenção de dor ou nocipecção asma fibrose cistica emese e processo para a preparação de um composto
BRPI0314325B8 (pt) derivados de aza-bicicloalquila, seu uso, seu processo de preparação e composição farmacêutica que os compreende
EP1400518A4 (en) DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTS
UY25804A1 (es) Derivados de 4-aroilpiperidina que son antagonistas de los receptores ccr-3
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
DE602004031722D1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
DE69434888D1 (de) 5-ht4-rezeptor-antagonisten
EA199900608A1 (ru) Новые ингибиторы фарнезилтрансферазы, способы их получения, содержащие их фармацевтические композиции и их применение для получения медикаментов
EA200600061A1 (ru) Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
AU6785201A (en) Novel pyrazinone derivatives
EP0351385A3 (en) New amidino and guanidino derivatives
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
WO1999062893A3 (de) Neue neurokininantagonisten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
WO1998053790A3 (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
NZ520155A (en) Thienopyridine derivatives, their production and use
EP0630893A4 (en) N, N&#39;-DISUBSTITUTED AMIDE DERIVATIVES.
ES2012687A6 (es) Procedimiento de preparacion de derivados 1,4-dihidro-piridinas.
MY136065A (en) Prodrugs to nmda receptor ligands
BR0315996A (pt) Derivados de 2,3-dihidro-4(1h)-piridinonas, seu processo de preparo e as composições farmacêuticas que os contêm
BR0101466A (pt) Compostos de ciclobutaindolcarboxamida,processo para a sua preparação e composiçõesfarmacêuticas contendo os mesmos
PT1572198E (pt) Novos compostos farmaceuticos com actividade de receptor alfa2.
DE69626624D1 (de) Medikamente gegen trhombocytopenie

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 405/14, 413/14, 401/12, 405/12, 211/58; A61K 31/443, 31/4525, 31/453, 31/454, 31/4545, 31/497; A61P 1/08

Ipc: C07D 405/14 (2011.01), C07D 413/14 (2011.01), C07D

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2274 DE 05/08/2014.